June 16, 2020
Jun 16, 2020
Medical Director | DVC Stem
DVC Stem is an innovative stem cell therapy clinic in the Cayman Islands. The clinic’s Medical Director, Louis A. Cona, MD, is a pioneer in regenerative cell therapy, providing the first stem cell treatments in the Cayman Islands more than a decade ago. He continues to research alternative therapies for various medical conditions, and with IRB certified clinical trials, has treated local and international patients for Multiple Sclerosis (MS), Chronic Low Grade Inflammation (which is part of the overall Aging Process), and many other degenerative conditions.
Louis A. Cona, MD is certified by the American Academy of Aesthetic Practitioners, and is also a member of the World Academy of Anti-Aging Medicine (WAAAM). He is a recognized member of the British Medical Association, the General Medical Council (UK), the Caribbean College of Family Physicians, and the American Academy of Family Physicians.
There are at least four areas that make DVC Stem unique, which are described below.
DVC Stem uses cutting edge stem cell treatments for a range of conditions. Because of the innate property stem cells have for being attracted to inflammation in the body, studies have shown that stem cells can regenerate damaged or diseased tissues, promoting better health and quality of life.
DVC Stem’s staff is fully licensed and the facility is accredited by the medical governing bodies of the Cayman Islands. Their cells are sourced from Vitro Biopharma Inc, a state of the art, US-based, FDA registered, cGMP compliant and ISO 9001 certified laboratory.
At DVC Stem, patient care is the top priority. Its team of specialists work tirelessly to provide a safe; regenerative experience.
For over a decade, the physicians at DVC Stem have been using complimentary therapies to clinically treat patients with various medical conditions. DVC Stem is one of the most advanced stem cell clinics in North America.
DVC Stem’s IRB-approved allogeneic stem cell treatment incorporates the highest quality US-donated cord tissue-derived mesenchymal stem cells, as well as a variety of included supporting therapies to aid in cell activation.
It offers Cord Tissue-Derived, Mesenchymal Stem Cell (CT-MSC) Therapy, which can be deployed systemically via IV, or injected locally to target specific sites, depending on patient needs. Its cells are only sourced from American Association of Tissue Bank (AATB) certified suppliers of full term, ethically US donated human umbilical cords. Its treatment protocols are independently IRB reviewed by a medical board in the US to ensure that its practices are safe and within good standing in the medical community.
DVC Stem treats a variety of conditions including: ALS, Alzheimer’s, Arthritis, Autism, Autoimmune, Brochial Asthma, Cardiovascular Disease, COPD, Diabetes (Type 1), Fibromyalgia, Heart Disease, Kidney Disease, Liver Disease, Lupus, Lyme, Multiple Sclerosis, Neuropathy, Osteoarthritis, Parkinson’s, Reflex Sympathetic Dystrophy, Spinal Cord Injuries, Stroke, Traumatic Brain Injury.
It also provides therapy for anti-aging, erectile dysfunction, hair loss, age related memory loss, joint pain, mobility issues, sports related injuries and tissue damage.
DVC Stem is partnered with Vitro Biopharma, an award-winning medical laboratory located in Golden, Colorado, which is fully FDA registered, cGMP compliant, ISO 9001, and ISO 13485 certified. Cells are only sourced from American Association of Tissue Bank (AATB) certified suppliers of full term, ethically US donated human umbilical cords. The selection of these donated tissues is extremely regulated and strict. All of its cells are expanded using safe and standard protocols and are then flown overnight in sub-zero containers directly to our clinic for immediate treatment. To ensure maximum treatment effectiveness, its cells are expanded to as much as 300 million cells before being administered. For more info on its partner lab, visit www.vitrobiopharma.com.
DVC Stem uses cord tissue-derived mesenchymal stem cells sourced from US-donated, full term human umbilical cords. While other common sources of stem cells are fat tissue or bone marrow taken from the patient directly, there are many benefits to using cord tissue. Cord tissue-derived cells are in their most primal state, free from the effects of aging or disease.
Stem cells age as we age, and cells taken from a patient are affected by the condition of the patient at the time of extraction. There is even evidence to suggest that cells extracted from patients with existing medical conditions risk reintroducing these symptoms when used in treatments. Cord tissue-derived stem cells eliminate that risk. Additionally, they are readily available, in great supply, and are minimally invasive to the patient, without the need for any extractions, free from immune rejection, and have zero risk of transferring viruses or other communicable diseases.
Dr. Cona believes in only offering treatments for conditions that have medical research backing positive results and no harmful side effects. Dozens of studies have shown the efficacy of stem cell therapies for various degenerative diseases, and DVC has had great success from past patients. However, it is impossible to guarantee any specific result for an individual, as every person’s body is different and will respond in different ways.
DVC Stem has been treating patients for over 15 years; the majority of their patients have reported increased quality of life. Their personal experiences and length of effects are different, due to a variety of biological factors. To quantify specific results, their protocol involves testing for certain inflammation markers prior to treatment, and then again at intervals following treatment. This data is used in conjunction with future prognosis to determine of the effects the treatment had on a patient’s condition. This data is vital to the on-going research being conducted on the efficacy of Allogeneic Stem Cell Therapy.
DVC Stem has treated hundreds of patients including Lou Ferrigno, Michael Armand Hammer & David Lyons (MS Fitness Challenge – Founder).
DVC Stem has become a cornerstone of the medical tourism industry, its protocols are IRB approved, and its cells come from regulated, U.S. based, FDA compliant laboratories.
DVC Stem is located in Grand Cayman, a small island paradise in the Caribbean. The Cayman Islands is an English-speaking British Overseas Territory and hosts over 2 million tourists a year. There are many direct flights to Grand Cayman from major cities in the U.S. and Europe.
Despite the clinical evidence, the United States still has very strict regulations and laws against stem cell treatments. While you may find many clinics in the US offering “stem cell therapies”, these therapies are highly restricted in scope and number of cells used, or simply send you outside the US for treatment.
These clinics usually draw patients in and then refer them to places like Mexico or Panama, where regulations are much looser and the source of the cells used is unknown. This can be both an unpleasant and an unsafe choice. It is currently not legal to obtain expanded allogeneic treatment inside the U.S. The expansion is what allows the high cell numbers needed for effective treatment. It is because of these laws in the U.S. that many have traveled abroad to receive the latest therapies, including many high-profile athletes and celebrities. It has created a booming medical tourism industry in the last decade. DVC Stem seeks to provide patients with safe and effective treatments, in a safe, luxurious, and beautiful setting.
DVC Stem uses cord tissue-derived mesenchymal stem cells sourced from US-donated, full term human umbilical cords. While other common sources of stem cells are fat tissue or bone marrow taken from the patient directly, there are many benefits to using cord tissue. Cord tissue-derived cells are free from the effects of aging or disease. Stem cells age as we age, and cells taken from a patient are affected by the condition of the patient at the time of extraction. There is even evidence to suggest that cells extracted from patients with existing medical conditions risk reintroducing these symptoms when used in treatments. Cord tissue-derived stem cells eliminate that risk. Additionally, they are readily available, in great supply, and are minimally invasive to the patient, without the need for any extractions, free from immune rejection, and have zero risk of transferring viruses or other communicable diseases.
Treatment is tailored to each individual patient to patient basis depending on their specific conditions and requirements, so there are no set costs. DVC Stem’s most advanced, multi-day allogeneic treatments can cost up to $25,000 USD (Find out why here). DVC Stem also offers full concierge service for an additional cost.
The service includes trip planning, airfare, luxury accommodation, and transportation to/from the airport as a complete package. For special pricing on MS treatments for MS Fitness Challenge members, contact us at firstname.lastname@example.org or call 877-DVC-STEM.
DVC Stem is also one of the only clinics offering financing for US residents.
“We try to make treatment as accessible to as many people as possible, we have partnered with Advance Care to offer patient friendly and transparent financing options” – Dr. Louis A. Cona
About the author
Dr. Cona has been performing stem cell therapy for over 10 years. He is a member of the World Academy of Anti-Aging Medicine (WAAAM). He is also a recognized member of the British Medical Association, the General Medical Council (UK), the Caribbean College of Family Physicians, and the American Academy of Family Physicians. He is the Medical Director for DVC Stem a world-renowned stem cell therapy clinic located in Grand Cayman.
Are you a candidate for stem cell treatment?
Complete our brief online application to find out if our IRB-approved mesenchymal stem cell treatment is right for you.Apply for treatment
You might also like...
The borders of the Cayman Islands are in a phased reopening process, which will expand within the next couple of months. This means that the airport is open but travel must be approved by the Cayman Islands Government & all visitors must participate in a mandatory 10 - 14 day quarantine.
Stem cell therapy results have been extremely positive so far, with approximately 75% of Multiple Sclerosis patients reporting significant improvement within 3 months of treatment, and showing little to no signs of regression out to 18-24 months. Our full Multiple Sclerosis study results are expected to be published later this year.
New study has found mesenchymal stem cells to be both a safe and effective treatment option for stroke.
Are people with Multiple Sclerosis more prone to severe Coronavirus related illness? Having a compromised immune system could potentially increase one’s risk of developing severe Coronavirus symptoms. This article aims to answer this question as well as describe the actions MS patients should take to mitigate risk.
Explaining the relationship between stem cell therapy and Parkinson's.
DVC STEM, GRAND CAYMAN